puc-header

LncRNA Interpreter: A Protein-Centric Pipeline for Mechanistic Analysis of Long Noncoding RNAs

51 Pages Posted: 23 Oct 2018 Publication Status: Published

See all articles by Xianzhi Lin

Xianzhi Lin

Cedars Sinai Medical Center - Women's Cancer Program

Tassja J. Spindler

Cedars Sinai Medical Center - Women's Cancer Program

Marcos Abraão de Souza Fonseca

University of Sao Paulo (USP), Medical School, Department of Genetics

Rosario I. Corona

Cedars Sinai Medical Center - Women's Cancer Program

Ji-Heui Seo

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

Felipe Segato Dezem

University of Sao Paulo (USP), Medical School, Department of Genetics

Lewyn Li

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

Janet M. Lee

Cedars Sinai Medical Center - Center for Bioinformatics and Functional Genomics

Henry W. Long

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

Thomas A. Sellers

H. Lee Moffitt Cancer Center and Research Institute - Department of Cancer Epidemiology

Beth Y. Karlan

Cedars Sinai Medical Center - Women's Cancer Program

Houtan Noushmehr

Henry Ford Health System - Department of Neurosurgery

Matthew L. Freedman

Dana-Farber/Harvard Cancer Center - Center for Functional Cancer Epigenetics

Simon A. Gayther

Cedars Sinai Medical Center - Center for Bioinformatics and Functional Genomics

Kate Lawrenson

Cedars Sinai Medical Center - Women's Cancer Program

More...

Abstract

Long noncoding RNAs (lncRNAs) have emerged as critical regulators of tumorigenesis and yet their mechanistic role remains challenging to characterize. Here, we present LncRNA Interpreter, a pipeline integrating functional proteomics with interacting proteins to characterize lncRNAs. Its robustness is exemplified by lncRNA Urothelial Cancer Associated 1 (UCA1), a driver of ovarian cancer development. Reverse phase protein array (RPPA) analysis indicates that UCA1 activates Hippo-YAP signaling and in vivo RNA antisense purification (iRAP) of UCA1 interacting proteins identified angiomotin (AMOT), a known YAP regulator, as direct binding partner. Loss-of-function experiments show that AMOT mediates Hippo-YAP signaling activation by UCA1. UCA1 enhances the AMOT-YAP interaction to prevent YAP phosphorylation and facilitate its nuclear translocation. Together, our LncRNA Interpreter pipeline identified UCA1 as an lncRNA regulator of the Hippo-YAP signaling and highlighted the UCA1-AMOT-YAP signaling axis in ovarian cancer development. LncRNA Interpreter can readily be applied to other lncRNAs implicated in complex diseases.

Suggested Citation

Lin, Xianzhi and Spindler, Tassja J. and Fonseca, Marcos Abraão de Souza and Corona, Rosario I. and Seo, Ji-Heui and Dezem, Felipe Segato and Li, Lewyn and Lee, Janet M. and Long, Henry W. and Sellers, Thomas A. and Karlan, Beth Y. and Noushmehr, Houtan and Freedman, Matthew L. and Gayther, Simon A. and Lawrenson, Kate, LncRNA Interpreter: A Protein-Centric Pipeline for Mechanistic Analysis of Long Noncoding RNAs (October 23, 2018). Available at SSRN: https://ssrn.com/abstract=3271630 or http://dx.doi.org/10.2139/ssrn.3271630
This version of the paper has not been formally peer reviewed.

Xianzhi Lin

Cedars Sinai Medical Center - Women's Cancer Program

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Tassja J. Spindler

Cedars Sinai Medical Center - Women's Cancer Program

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Marcos Abraão de Souza Fonseca

University of Sao Paulo (USP), Medical School, Department of Genetics

Rua Luciano Gualberto, 315
Sao Paulo
Brazil

Rosario I. Corona

Cedars Sinai Medical Center - Women's Cancer Program

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Ji-Heui Seo

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

450 Brookline Avenue
Boston, MA 02115
United States

Felipe Segato Dezem

University of Sao Paulo (USP), Medical School, Department of Genetics

Rua Luciano Gualberto, 315
Sao Paulo
Brazil

Lewyn Li

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

450 Brookline Avenue
Boston, MA 02115
United States

Janet M. Lee

Cedars Sinai Medical Center - Center for Bioinformatics and Functional Genomics

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Henry W. Long

Dana-Farber Cancer Institute/Harvard Medical School - Department of Medical Oncology

450 Brookline Avenue
Boston, MA 02115
United States

Thomas A. Sellers

H. Lee Moffitt Cancer Center and Research Institute - Department of Cancer Epidemiology

12902 USF Magnolia Drive
Tampa, FL 33612
United States

Beth Y. Karlan

Cedars Sinai Medical Center - Women's Cancer Program

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Houtan Noushmehr

Henry Ford Health System - Department of Neurosurgery ( email )

Detroit, MI
United States

Matthew L. Freedman

Dana-Farber/Harvard Cancer Center - Center for Functional Cancer Epigenetics

450 Brookline Avenue
Boston, MA 02115
United States

Simon A. Gayther

Cedars Sinai Medical Center - Center for Bioinformatics and Functional Genomics

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Kate Lawrenson (Contact Author)

Cedars Sinai Medical Center - Women's Cancer Program ( email )

8700 Beverly Blvd.
Los Angeles, CA 90048
United States

Click here to go to Cell.com

Paper statistics

Downloads
31
Abstract Views
831
PlumX Metrics